Related Experiment Video
Updated: Aug 19, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
[Antithrombotic therapy of acute coronary syndromes]
1Medizinische Klinik I, Kardiologie und Angiologie, Zentrum für Innere Medizin, Universitätsklinikum Giessen, Klinikstr. 36, 35392 Giessen. hoelschermann@uni-giessen.de
Insights
Recent advances in acute coronary syndromes (ACS) treatment have improved patient outcomes. This review highlights current antithrombotic therapy recommendations for non-ST-elevation ACS, emphasizing combined treatments and early invasive strategies.
Area of Science:
- Cardiology
- Internal Medicine
- Pharmacology
Background:
- Recent advancements in acute coronary syndromes (ACS) diagnosis and treatment have significantly reduced major coronary events and improved patient outcomes.
- New clinical guidelines have been established based on these therapeutic improvements.
- Current treatment strategies for non-ST-elevation ACS involve combined antithrombotic therapies.
Purpose of the Study:
- To review and present current recommendations for the effective use of antithrombotic strategies in patients with acute coronary syndromes.
- To highlight the benefits of combined antithrombotic therapy in conjunction with early invasive approaches.
Main Methods:
- Literature review of recent advances in ACS treatment.
- Analysis of current guidelines for antithrombotic therapy in non-ST-elevation ACS.
- Discussion of combined antithrombotic regimens including aspirin, clopidogrel, heparins, and glycoprotein IIb/IIIa inhibitors.
Main Results:
- Combined antithrombotic therapy, including aspirin, clopidogrel, heparins, and potentially glycoprotein IIb/IIIa receptor antagonists, is recommended for non-ST-elevation ACS.
- This therapeutic approach enhances the benefits of early invasive strategies, such as coronary angiography with stent percutaneous coronary angioplasty.
Conclusions:
- Appropriate antithrombotic strategies are crucial for optimizing outcomes in ACS patients.
- The integration of combined antithrombotic therapy with early invasive procedures represents the current standard of care for non-ST-elevation ACS.
Abstract:
Recent advances in the diagnosis and the treatment of acute coronary syndromes (ACS) have led to a substantial reduction of major coronary events, to an improvement in patient outcome, and to the definition of new guidelines. Current strategies for the treatment of patients with non-ST-elevation ACS recommend a combined antithrombotic therapy (including acetyl salicylic acid, clopidogrel, low-molecular weight or unfractionated heparins and, eventually glycoprotein IIb/IIIa receptor antagonists). This combined antithrombotic therapy allows to increase the benefit of an early invasive strategy including coronary angiogram with stent percutaneous coronary angioplasty. The purpose of this review is to discuss and highlight the actual recommendations for the appropriate use of antithrombotic strategies for ACS patients.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome V: Nursing Management
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
